<DOC>
	<DOCNO>NCT01298063</DOCNO>
	<brief_summary>Up 38 subject enter aim enter 8 subject mild liver impairment ( high dose afatinib ) , 8 subject moderate liver impairment ( either high dose two low dos ) 8 healthy match control two group .</brief_summary>
	<brief_title>Influence Mild Moderate Hepatic Impairment Pharmacokinetics , Safety Tolerability Various Doses Afatinib</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>Inclusion criterion : Healthy subject : 1 . Healthy male female accord complete medical history , include physical examination , vital sign ( Blood Pressure , Pulse Rate ) , 12lead Electrocardiogram , clinical laboratory test . The healthy subject must meet match criterion base match approach ( cf . Section 3.3 ) . 2 . Age =18 =75 year 3 . Body Mass Index =18.5 =34 kg/m2 4 . Creatinine clearance &gt; 70 mL/min accord Cockroft &amp; Gault ( healthy volunteer , cf . Section 10.2 ) 5 . Signed date write informed consent prior admission study accordance Good Clinical Practice local legislation . Hepatically impaired subject determine hepatologist/ gastroenterologist : 6 . Male female liver impaired subject determine result screen classify ChildPugh A ; ChildPugh score 56 point ChildPugh B ; ChildPugh score 79 point , cf . Section 10.2 . ChildPugh criterion must stable least 3 month prior screen trial . 7 . Age =18 =75 year 8 . Body Mass Index =18.5 =34 kg/m2 9 . Creatinine clearance &gt; 40 mL/min accord Cockroft &amp; Gault ( liver impair subject , cf . Section 10.2 ) 10 . Signed date write informed consent prior admission study accordance Good Clinical Practice local legislation . For female : 11 . Postmenopausal female subject ( postmenopausal define least 1 year spontaneous amenorrhea [ questionable case spontaneous amenorrhea 1 year blood sample simultaneous follicle stimulate hormone ( FSH ) 40 IU/l estradiol 30 ng/l confirmatory ] ) adequate contraception* female subject childbearing potential study 2 month study completion , e.g . follow : implant , injectables , combine oral contraceptive , IUD ( intrauterine device ) , sexual abstinence least 1 month prior first study drug administration , vasectomise partner ( vasectomy perform least 1 year prior enrolment ) , surgical sterilisation ( include hysterectomy ) . Females , vasectomise partner , sexually abstinent surgically sterile use additional barrier method ( e.g . condom ) . Exclusion criterion : Any relevant deviation healthy condition ( excluded condition cause liver impairment )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>